Exploring Impact of Surgery Delays for Clinical Renal Cell Carcinoma Patients During the COVID-19 Pandemic
February 12, 2021
February 12, 2021
NEW BRUNSWICK, New Jersey, Feb. 12 -- Rutgers Cancer Institute of New Jersey issued the following news:
During the peak of the COVID-19 pandemic, several elective surgeries for renal cell carcinoma, the most common type of kidney cancer, were delayed with unknown impact on outcomes for patients. In a retrospective study, researchers at Rutgers Cancer Institute of New Jersey explored the impact of surgery delays for these patients throughout the United States by utilizing the Nationa . . .
During the peak of the COVID-19 pandemic, several elective surgeries for renal cell carcinoma, the most common type of kidney cancer, were delayed with unknown impact on outcomes for patients. In a retrospective study, researchers at Rutgers Cancer Institute of New Jersey explored the impact of surgery delays for these patients throughout the United States by utilizing the Nationa . . .